CAS 668985-31-7

Esomeprazole magnesium hydrate

CAS: 668985-31-7

Formel: C₃₄H₃₈MgN₆O₇S₂

Molekulargewicht: 731.1365

Ref: IN-DA00FGJK

Esomeprazole magnesium salt hydrate

CAS: 668985-31-7

Formel: C₃₄H₃₆MgN₆O₆S₂·xH₂O

Reinheit: ≥ 98.0% (dried basis)

Farbe und Form: White to off-white powder

Molekulargewicht: 713.12 (anhydrous)

Ref: 7W-GL1313

Esomeprazole Magnesium

Kontrolliertes Produkt

CAS: 668985-31-7

Stability Hygroscopic
Applications S-Form of Omeprazole. Gastric proton-pump inhibitor.
References Stenhoff, H., et al.: J. Chromatogr., 734, 191 (1999), Johnson, D.A., et al.: Expert Opin. Pharmacother., 4, 253 (2003),

Formel: C₃₄H₃₆MgN₆O₆S₂·xH₂O

Farbe und Form: Neat

Molekulargewicht: 731.14

Ref: TR-E668300

Esomeprazole magnesium hydrate

CAS: 668985-31-7

Esomeprazole magnesium hydrate is a proton pump inhibitor that inhibits the secretion of acid by the stomach. It is used for the treatment of gastroesophageal reflux disease and peptic ulcers. Esomeprazole magnesium hydrate belongs to a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs inhibit prostaglandin synthesis, which is required for pain and inflammation. The effects of this drug are dose-dependent. Esomeprazole magnesium hydrate has been shown to be toxic in animal studies, with effects on stomach, liver, kidneys, heart, lungs, and spleen. This drug has also been shown to interact with other medications such as omeprazole sodium and omeprazole.

Formel: C₁₇H₁₉N₃O₃S

Reinheit: Min. 95%

Molekulargewicht: 345.4 g/mol

Ref: 3D-TBB98531